CV Sciences (CVSI) EBT Margin Growth (3y) (2016 - 2026)
CV Sciences (CVSI) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 660.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 660.00 |
| Mar 31, 2026 | -15,769.00 |
| Dec 31, 2025 | 6,598.00 |
| Sep 30, 2025 | 1,575.00 |
| Jun 30, 2025 | 5,685.00 |
| Mar 31, 2025 | 4,473.00 |
| Dec 31, 2024 | 16,788.00 |
| Sep 30, 2024 | -1,101.00 |
| Jun 30, 2024 | 5,385.00 |
| Mar 31, 2024 | 4,901.00 |
| Dec 31, 2023 | 15,911.00 |
| Sep 30, 2023 | 4,581.00 |
| Jun 30, 2023 | 5,398.00 |
| Mar 31, 2023 | 20,177.00 |
| Dec 31, 2022 | 1,753.00 |
| Sep 30, 2022 | -1,347.00 |
| Jun 30, 2022 | -7,151.00 |
| Mar 31, 2022 | 1,537.00 |
| Dec 31, 2021 | -19,958.00 |
| Sep 30, 2021 | -2,648.00 |